Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
Cancer02:18

Cancer

49.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Congenital Pulmonary Airway Malformations in Children: Beyond the Pulmonary Cystic Lesion Is There Really an Associated Laryngo-Tracheal Abnormality?

Pediatric pulmonology·2026
Same author

Cross-cultural adaptation of the Italian Chronic Rhinosinusitis Patient-Reported Outcome. Questionnaire.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2026
Same author

Post-adenotonsillectomy pharyngeal stenosis in children - a systematic review.

International journal of pediatric otorhinolaryngology·2026
Same author

A Deceiving Massive Opacification of the Maxillary Sinus: Odontogenic Cyst Mimicking Odontogenic Sinusitis.

Clinical case reports·2026
Same author

Guideline-Integrated Large Language Models Improve Decision Support for Acute Ear, Nose and Throat Emergencies.

The Journal of emergency medicine·2026
Same author

Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-naïve patients.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026

Related Experiment Video

Updated: Sep 3, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

617

Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach.

Antonio Mario Bulfamante1, Eleonora Lori2, Maria Irene Bellini2

  • 1Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.

Frontiers in Oncology
|July 25, 2022
PubMed
Summary

This study examined 111 advanced differentiated thyroid cancers (DTCs), finding that a tailored, multidisciplinary approach is crucial for managing complex cases and improving patient outcomes. Radical excision and complication rates were key focus areas.

Keywords:
differentiated carcinomafollicular carcinomalymph node dissectionpapillary carcinomathyroidthyroid cancerthyroidectomy

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.9K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Related Experiment Videos

Last Updated: Sep 3, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

617
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.9K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Endocrinology

Background:

  • Differentiated thyroid cancers (DTCs) generally have a good prognosis but can worsen with advanced disease (local invasion, nodal metastasis, distant spread).
  • Current literature lacks specific guidelines for managing advanced DTCs, highlighting the need for individualized, multidisciplinary strategies.
  • Surgery is the primary treatment, but radical excision can be challenging, leading to significant morbidity in advanced cases.

Purpose of the Study:

  • To evaluate the outcomes of treating 111 advanced differentiated thyroid cancers (DTCs) at a single center.
  • To assess the feasibility of radical excision, associated complications, quality of life, and long-term results (persistence, recurrence, survival).
  • To compare these findings with existing literature and inform clinical practice.

Main Methods:

  • Retrospective analysis of 111 patients with advanced (local, regional, distant) DTCs treated at a single institution.
  • Data collection included surgical outcomes, peri- and post-procedural complications, quality of life assessments, and follow-up for disease persistence, recurrence, and survival.
  • Results were critically appraised and compared against a review of published evidence.

Main Results:

  • Detailed surgical outcomes, complication rates, quality of life data, and survival statistics for advanced DTCs were analyzed.
  • The study provides insights into the challenges and successes of managing complex DTC cases.
  • Comparison with existing literature aims to identify best practices for advanced thyroid cancer treatment.

Conclusions:

  • A tailored, multidisciplinary approach is essential for optimizing the management of advanced differentiated thyroid cancers.
  • Understanding complication rates and quality of life is vital for comprehensive patient care in advanced DTC.
  • This single-center experience contributes valuable data for refining treatment strategies and improving survival in advanced thyroid cancer.